Shares of Biomarin Pharmaceutical Inc. topped $80 Thursday morning, one day after hitting a previous 52-week high. Although the stock (NASDAQ:BMRN) lost some lift late in the day, closing up 90 cents at $78.39, the uptick still pushed the company’s market cap to $11 billion.